Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 26 (RPL29P26)

Target
RPL29P26
Molecular classification
Other (Processed pseudogene)
01

Overview

Ribosomal protein L29 pseudogene 26 (RPL29P26) is a processed, non-coding pseudogene related to the ribosomal protein L29 gene (RPL29). Pseudogenes like RPL29P26 do not encode functional proteins and are generally considered genomic relics without direct biological activity. RPL29P26 is listed as a pseudogene in genomic databases and does not participate in ribosome function, drug interactions, or recognized disease pathways. Pseudogenes are typically non-functional sequences in the genome, often resulting from duplication or retrotransposition events. They share high sequence homology with their functional counterpart genes but are unable to produce functional proteins because of disabling mutations (e.g., premature stop codons or frameshifts). RPL29P26 does not encode a functional protein and is therefore not considered a therapeutic target, receptor, enzyme, transporter, or functional cellular component. There are no known biological functions, disease roles, or therapeutic implications attributed to RPL29P26. It is not a biomarker, is not involved in drug interactions, and has no known associated safety concerns. RPL29P26 is not a functional gene product or therapeutic target, but a processed ribosomal pseudogene. There is nothing to suggest it is misspelled, but its inclusion as a biomedical target would be incorrect due to its lack of protein expression or direct biological function.

Other names
RPL29_14_1268

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 26 (RPL29P26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 26 (RPL29P26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call